skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: AUC Wiley Frozen Package in 2012 remover Base de dados/Biblioteca: MEDLINE Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors

Odeh, Dana M. ; Allam, Heba Abdelrasheed ; Baselious, Fady ; Mahmoud, Walaa R. ; Odeh, Mohanad M. ; Ibrahim, Hany S. ; Abdel‐Aziz, Hatem A. ; Mohammed, Eman R.

Drug development research, 2024-05, Vol.85 (3), p.e22193-n/a [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Novel Antiviral Compounds against Gastroenteric Viral Infections
Novel Antiviral Compounds against Gastroenteric Viral Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel Antiviral Compounds against Gastroenteric Viral Infections

Mohamed, Mosaad S. ; Abd El-Hameed, Rania H. ; Sayed, Amira I. ; Soror, Sameh H.

Archiv der Pharmazie (Weinheim), 2015-03, Vol.348 (3), p.194-205 [Periódico revisado por pares]

Germany: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure‐Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib
Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure‐Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure‐Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib

Mohamed, Mohamed‐Eslam F. ; Beck, Denise ; Camp, Heidi S. ; Othman, Ahmed A.

Journal of clinical pharmacology, 2020-02, Vol.60 (2), p.188-197 [Periódico revisado por pares]

England: American College of Clinical Pharmacology

Texto completo disponível

Citações Citado por
4
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds
Material Type:
Artigo 		Adicionar ao Meu Espaço

Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds

Istanbullu, Huseyin ; Bayraktar, Gulsah ; Akbaba, Hasan ; Cavus, Ibrahim ; Coban, Gunes ; Debelec Butuner, Bilge ; Kilimcioglu, Ali Ahmet ; Ozbilgin, Ahmet ; Alptuzun, Vildan ; Erciyas, Ercin

Archiv der Pharmazie (Weinheim), 2020-08, Vol.353 (8), p.e1900325-n/a [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities
Material Type:
Artigo 		Adicionar ao Meu Espaço

1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities

Mokariya, Jaydeep A. ; Rajani, Dhanji P. ; Patel, Manish P.

Archiv der Pharmazie (Weinheim), 2023-04, Vol.356 (4), p.e2200545-n/a [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder

Lalovic, Bojan ; Majid, Oneeb ; Aluri, Jagadeesh ; Landry, Ishani ; Moline, Margaret ; Hussein, Ziad

Journal of clinical pharmacology, 2020-12, Vol.60 (12), p.1642-1654 [Periódico revisado por pares]

England: American College of Clinical Pharmacology

Texto completo disponível

Citações Citado por
7
Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4‐amino‐5‐cyanopyrimidine) derivatives
Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4‐amino‐5‐cyanopyrimidine) derivatives
Material Type:
Artigo 		Adicionar ao Meu Espaço

Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4‐amino‐5‐cyanopyrimidine) derivatives

Boualia, Imen ; Derabli, Chamseddine ; Boulcina, Raouf ; Bensouici, Chawki ; Yildirim, Muhammet ; Birinci Yildirim, Arzu ; Mokrani, El Hassen ; Debache, Abdelmadjid

Archiv der Pharmazie (Weinheim), 2019-11, Vol.352 (11), p.e1900027-n/a [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
Sensitive CE‐MS method for monitoring of riociguat and desmethylriociguat levels in human serum
Sensitive CE‐MS method for monitoring of riociguat and desmethylriociguat levels in human serum
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sensitive CE‐MS method for monitoring of riociguat and desmethylriociguat levels in human serum

Hložek, Tomáš ; Štícha, Martin ; Bursová, Miroslava ; Jelínek, Ivan ; Tůma, Petr ; Čabala, Radomír

Electrophoresis, 2020-10, Vol.41 (18-19), p.1564-1567 [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors
Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors

Wang, Zhao ; Kang, Dongwei ; Chen, Meng ; Wu, Gaochan ; Feng, Da ; Zhao, Tong ; Zhou, Zhongxia ; Huo, Zhipeng ; Jing, Lanlan ; Zuo, Xiaofang ; Daelemans, Dirk ; De Clercq, Erik ; Pannecouque, Christophe ; Zhan, Peng ; Liu, Xinyong

Chemical biology & drug design, 2018-12, Vol.92 (6), p.2009-2021 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
10
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

Winthrop, Kevin L. ; Yamanaka, Hisashi ; Valdez, Hernan ; Mortensen, Eric ; Chew, Robert ; Krishnaswami, Sriram ; Kawabata, Thomas ; Riese, Richard

Arthritis & rheumatology (Hoboken, N.J.), 2014-10, Vol.66 (10), p.2675-2684 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (2.774)
  2. Revistas revisadas por pares (2.943)

Idioma 

  1. Inglês  (3.045)
  2. Japonês  (557)
  3. Alemão  (113)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.